Salicin: The Wild Compound That Gave the World Aspirin

There is a moment in the history of medicine that tends to get told the wrong way. The usual story goes: scientists extracted a compound from willow bark, refined it into salicylic acid, acetylated it to reduce stomach irritation, and the result was aspirin — the most widely used drug in human history. Clean, linear, triumphant.

What the story leaves out is meadowsweet.

It was Filipendula ulmaria — not willow — that provided the key chemical in the synthesis of acetylsalicylic acid. In 1838, Italian chemist Raffaele Piria isolated salicylaldehyde from meadowsweet flower buds. The following decade, French chemist Charles Gerhardt synthesised acetylsalicylic acid using salicylic acid derived in part from meadowsweet. When Felix Hoffmann at Bayer registered the compound in 1899, the name he chose — aspirin — came from Spirea, the former genus name of meadowsweet. A for acetyl, spir for Spiraea ulmaria. The drug was named after the plant, not the tree.

And yet meadowsweet has been largely written out of the story. It grows quietly in damp meadows across Britain, flowers creamily in late May and June, and carries within its tissues a chemistry that 6,000 years of human medicine recognised long before any laboratory did.

What salicin actually is

Salicin is a phenolic glycoside — a molecule consisting of a salicyl alcohol unit attached to a glucose molecule. It is found in significant concentrations in the bark and leaves of Salix species (willows) and in the flowers and herb of Filipendula ulmaria (meadowsweet), as well as in smaller amounts in other members of the Rosaceae and Salicaceae families.

In its intact form, salicin is pharmacologically relatively inert. The biological activity begins when the glucose unit is cleaved — either by gut bacteria during digestion or by beta-glucosidases in the intestinal wall — releasing salicyl alcohol, which is then oxidised in the liver to salicylic acid. It is this salicylic acid that produces the anti-inflammatory, analgesic, and antipyretic effects that have made salicylate-containing plants so valuable across cultures and centuries.

The metabolic pathway from salicin to salicylic acid is gentler and slower than the direct action of aspirin (acetylsalicylic acid). This distinction matters — and it is one of the reasons why meadowsweet preparations have historically been better tolerated by people with sensitive stomachs than synthetic aspirin.

Meadowsweet is not just a salicin delivery vehicle

This is where the research gets interesting — and where meadowsweet separates itself from willow bark as a medicinal plant in its own right.

A 2023 study from the University of Antwerp, published in Pharmaceutics (PMC10146082, Van der Auwera et al.), investigated the anti-inflammatory activity of Filipendula ulmaria using an in vitro gastrointestinal biotransformation model. The researchers tracked exactly what happens to meadowsweet’s complex mixture of compounds as they move through the gut — which compounds are absorbed intact, which are metabolised by gut bacteria in the colon, and which breakdown products are produced.

The results were illuminating. Meadowsweet contains not just salicylates but a rich array of glycosylated flavonoids — rutin, spiraeoside, isoquercitrin, hyperoside — that are poorly absorbed in the small intestine. Instead, they pass to the colon, where gut bacteria cleave the glycoside bonds and release the active flavonoid aglycons: quercetin, apigenin, naringenin, and kaempferol. These are compounds with well-documented anti-inflammatory profiles, each acting via complementary pathways.

Critically, both the genuine (pre-digestion) and biotransformed (post-digestion) meadowsweet extract showed significant inhibition of COX-1 and COX-2 enzymes — the cyclooxygenase enzymes responsible for prostaglandin synthesis and the inflammatory cascade. The study concluded that the anti-inflammatory activity of meadowsweet is the result of an additive or synergistic effect between salicylates, their metabolites, and the flavonoid aglycons released during digestion.

In other words, meadowsweet works the way whole plants tend to work: not through a single active compound, but through a constellation of interacting chemistry that no pharmaceutical has fully replicated.

The aspirin paradox: why meadowsweet protects what aspirin harms

Aspirin’s most significant side effect is gastric irritation. It inhibits COX-1, the cyclooxygenase enzyme that produces prostaglandins responsible for protecting the stomach lining — maintaining the mucus layer that prevents gastric acid from eroding the mucosa. Long-term aspirin use can cause gastric ulcers, bleeding, and in severe cases haemorrhage.

Meadowsweet presents a remarkable contrast. Traditional herbalism has long used it specifically for gastric conditions — as a remedy for heartburn, gastritis, peptic ulcers, and digestive discomfort. The explanation lies in meadowsweet’s tannin content. The plant is rich in hydrolysable tannins — particularly tellimagrandin I and II, and rugosin compounds — that have demonstrated gastroprotective and cytoprotective properties. These tannins form a protective layer on inflamed or irritated mucous membranes, reducing the direct irritant effects of the salicylates present in the same plant. The plant, in effect, contains both the anti-inflammatory compound and its own gastric antidote.

The historical analysis of aspirin’s discovery (PMC6496865, Mahdi et al., Cell Proliferation, 2006) traces salicylate medicine from Assyrian clay tablets (4000 BCE) through Hippocrates, Dioscorides, and into the modern synthesis of aspirin in 1899. For most of human history, salicylate medicine came packaged in whole plants — with their tannins, flavonoids, and co-occurring compounds intact. The isolation and acetylation of salicylic acid produced a more potent and standardised drug, but at the cost of that protective complexity.

The COX pathway explained simply

Cyclooxygenase (COX) enzymes are the gatekeepers of the inflammatory cascade. When tissue is damaged — whether by injury, infection, or chronic inflammatory disease — COX enzymes convert arachidonic acid into prostaglandins: signalling molecules that cause pain, fever, and inflammation.

COX-1 is constitutively expressed — always present, doing housekeeping. It produces prostaglandins that protect the stomach lining, support kidney function, and help platelets aggregate.

COX-2 is inducible — switched on by inflammatory signals. It is the primary target of anti-inflammatory drugs because inhibiting it reduces pain and inflammation.

Aspirin irreversibly inhibits both — which is why it works as an anti-inflammatory but causes stomach problems. Meadowsweet’s salicylate metabolites inhibit both COX enzymes, but less potently and reversibly than aspirin, combined with the gastroprotective tannins and additional flavonoids working via NF-κB and other pathways. The net effect is a multi-target anti-inflammatory action that is gentler and more broadly active than aspirin’s single-compound mechanism.

Where to find meadowsweet right now

Meadowsweet (Filipendula ulmaria) is at peak flowering right now — late May through June across most of England. Look for the feathery cream plumes in damp meadows, along riverbanks, and in wet ditches. The scent is warm, honeyed, and slightly almond-like — you will often smell it before you see it.

Willow (Salix spp.) bark is the other major salicin source, though harvesting bark risks damaging the tree and is not recommended for casual foraging. Young willow leaves and catkins in spring contain smaller amounts of salicin with less disruption to harvest.

How to use meadowsweet as a salicin source

Meadowsweet tea (traditional infusion): Pour freshly boiled water over 1–2 teaspoons of dried meadowsweet flowers per cup. Steep for 10 minutes, strain. The flavour is sweet and slightly almond-like. Up to three cups per day during acute symptoms of mild pain or fever.

Fresh flower infusion: Fresh meadowsweet flower heads steeped in cold or lightly warmed water with honey and lemon make a beautifully fragrant drink. Gentler than boiling but retains the delicate aromatic compounds alongside the salicylates.

Infused into cream for cooking: Steep fresh flower heads in warm cream for 30 minutes, strain. Use in panna cotta, ice cream, or custard. More culinary-aromatic than medicinal at this application, but the flavour is extraordinary.

Important cautions: People allergic to aspirin should avoid medicinal quantities of meadowsweet. Not recommended in pregnancy. Do not use alongside blood-thinning medications without consulting your GP.

The plant is still playing the whole piece

The history of aspirin is often told as a story of science improving on nature — taking a crude plant compound and making it purer, stronger, more reliable. And in many respects, this is true. Aspirin is more potent than meadowsweet tea.

But the story also illustrates something that gets lost in pharmaceutical thinking: the compounds we isolate from plants were never meant to work alone. They evolved in a complex chemical matrix — alongside tannins that protect mucous membranes, flavonoids that modulate immune responses, volatile oils that influence digestion, and dozens of other compounds that interact in ways we are still only beginning to understand.

Meadowsweet contains salicin. But it also contains the gastroprotective tannins that prevent salicin’s metabolites from irritating the stomach. It contains quercetin, apigenin, and kaempferol — released by gut bacteria during digestion — that add their own anti-inflammatory activity via NF-κB inhibition. It contains rutin, which supports capillary integrity and reduces inflammatory permeability.

Aspirin contains acetylsalicylic acid. It works extremely well for what it does. But it does not contain meadowsweet’s tannins, or its flavonoids, or its aromatic oils. The pharmaceutical took one instrument from the orchestra and turned up the volume. The plant is still playing the whole piece.

Further reading on this site

• Meadowsweet: the healer hidden in the damp meadow
• Apigenin: the flavonoid that quiets anxiety and improves sleep
• Quercetin: the spring flavonoid that supports cellular resilience
• Dame’s violet: the fragrant crucifer your hedgerow has been hiding

References

• PMC10146082 — Van der Auwera A et al. In vitro biotransformation and anti-inflammatory activity of constituents and metabolites of Filipendula ulmaria. Pharmaceutics. 2023.
• PMC6496865 — Mahdi JG et al. The historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative and anticancer potential. Cell Prolif. 2006.
• PMID: 16366042 — Fiebich BL, Chrubasik S. Effects of an ethanolic Salix extract on the release of selected inflammatory mediators in vitro. Phytomedicine. 2004.

Medical disclaimer

This content is for educational purposes only and does not constitute medical advice. Wild plants can be dangerous if misidentified. People allergic to aspirin or salicylates should avoid medicinal quantities of meadowsweet. Never consume any wild plant unless completely confident in your identification. Always consult your GP before using wild plants medicinally, particularly if you are pregnant, breastfeeding, or taking blood-thinning medications.